Ta. Mobio et al., Epigenetic properties of fumonisin B-1: Cell cycle arrest and DNA base modification in C6 glioma cells, TOX APPL PH, 164(1), 2000, pp. 91-96
Fumonisin B-1 produced by the fungus Fusarium moniliforme is a member of a
new class of sphinganine analogue mycotoxins that occur widely in the food
chain. Epidemiological studies associate FB1 with human oesophageal cancer
in China and South Africa. FB1 also causes acute pulmonary edema in pigs an
d equine leucoencephalomalacia. This disease is thought to be a consequence
of inhibition by FB1 of cellular ceramide synthesis in cells. To investiga
te further on this pathogenesis, the effect of FB1 was studied on cell viab
ility (3 to 54 mu M of FB1), protein (2.5 to 20 mu M of FB1) and DNA synthe
ses (2.5 to 50 mu M of FB1), and cellular cycle (3 to 18 mu M of FB1) of ra
t C6 glioma cells after 24 h incubation. The results of the viability test
show that FB1 induces 10 +/- 2% and 47 +/- 4% cell death with, respectively
, 3 and 54 mu M, in C6 cells. This cytotoxicity induced by FB1 was efficien
tly prevented when the cells were preincubated 24 h with vitamin E (25 mu M
). FB1 displays epigenetic properties since it induced hypermethylation of
the DNA (9-18 mu M). Inhibition of protein synthesis was observed with FB1
with an IC50 of 6 mu M showing that C6 glioma cells are very sensitive to F
B1; however, the synthesis of DNA was only slightly inhibited, up to 20 mu
M of FB1. The flow cytometry showed that the number of cells in phase S dec
reased significantly as compared to the control p = 0.01 from 18.7 +/- 2.5%
to 8.1 +/- 1.1% for 9 mu M FB1. The number of cells in phase G(2)/M increa
sed significantly as compared to the control (p less than or equal to 0.05)
from 45.7 +/- 0.4% to 54.8 +/- 1.1% for 9 mu M FB1, whereas no change occu
rs in the number of cells in the phase G(0)/G(1). These results show that c
ytotoxic concentrations of FB1 induce cellular cycle arrest in phase G(2)/M
in rat C6 glioma cells possibly in relation with genotoxic events. (C) 200
0 Academic Press.